Which medications in the drug class Integrase Inhibitors are used in the treatment of Pediatric HIV Infection?

Updated: Mar 05, 2020
  • Author: Delia M Rivera, MD; Chief Editor: Russell W Steele, MD  more...
  • Print

Integrase Inhibitors

HIV integrase is responsible for the transport and attachment of proviral DNA to host-cell chromosomes, allowing transcription of viral proteins.

Raltegravir (RAL, Isentress)

Raltegravir is an HIV-1integrase strand transfer inhibitor (INSTI). It is indicated for use in combination therapy regimens for the treatment of HIV infection in children who weigh at least 30 kg.

Dolutegravir (DTG, Tivicay)

Dolutegravir is an integrase strand transfer inhibitor (INSTI) that inhibits catalytic activity of HIV-1 integrase, an HIV encoded enzyme required for viral replication. It is approved for use in children aged ≥ 12 years who weigh at least 40 kg.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!